logo Hematology/Oncology Research Studies: Open for Enrollment Date: 08/07/19

Category: ONCOLOGY

Documentation and Delivery of Guideline-Consistent Treatment in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia (ALL)

NCT#/Phase: N/A
IRB#: 2018-078
Description: For nearly three decades, adolescents and young adults (AYA, 15-39 years old) with cancer demonstrated stagnant survival compared with younger and older patients. For this and other reasons, the National Cancer Institute considers AYAs to be a vulnerable population. One of the most common malignancies in the AYA population is acute lymphoblastic leukemia (ALL), which historically, is associated with poor survival in AYAs when compared with children. AYAs come in contact with the health care system in a larger variety of ways than do children or older adults, and the manner in which care is delivered varies widely. While outcome in AYAs with ALL has been explored in different ways, the delivery of cancer care has not been studied and may represent a crucial step in working to improve survival in AYAs with ALL. ACCL16N1CD was developed to evaluate this possible link between cancer care delivery and AYA ALL outcomes. Cancer care delivery involves both processes and structures of care. To gather inform
Inclusion: Inclusion Criteria 1. Newly diagnosed with either Ph- or Ph+ ALL between January 1st, 2012 and December 31st, 2016 2. Age at diagnosis: 15-39 years, inclusive 3. Both diagnosed and initially treated at the participating NCORP institution during Induction and post-Induction therapy (PIT)*
Enrollment Status: Open for enrollment
Principal Investigator(s): Carla Golden, MD
Contact(s): Christine Ho (510-428-3885 x 2609)
Diane Olzewski (510-428-3885 x 3246)
Study Link: #

UCSF Benioff Children's Hospital Oakland • 747 52nd Street, Oakland, California 94609 &bull Phone: (510) 428-3000